Apr 2020

Apr 07, 2020 Quarterly Cashflow and Activity Report

Mar 2020

Mar 30, 2020 COVID-19 measures

Mar 04, 2020 Okamoto licenses VivaGel® antiviral condom in Asian countries

Mar 02, 2020 Starpharma appoints David McIntyre and Appendix 3X

Feb 2020

Feb 24, 2020 Interim Report and Half-Year Financial Results

Feb 13, 2020 VivaGel BV launched in Asia

Feb 12, 2020 David McIntyre appointed as non-executive director

Feb 11, 2020 Starpharma receives US$3M milestone from AstraZeneca

Jan 2020

Jan 30, 2020 Shareholder Update January 2020

Jan 29, 2020 Quarterly Cashflow Report